Testing effectiveness (Phase 2)Study completedNCT00885495What this trial is testingDarunavir/Ritonavir and Rosuvastatin Pharmacokinetic StudyWho this might be right forHIV Infections University of Cincinnati 17
Testing effectiveness (Phase 2)Study completedNCT00626639What this trial is testingPalifermin for the Reduction of Oral Mucositis in Patients With Locally Advanced Head and Neck Cancer Receiving Postoperative Radiotherapy and Concurrent ChemotherapyWho this might be right forMucositisHead and Neck Cancer Swedish Orphan Biovitrum 5
Early research (Phase 1)Study completedNCT05496205What this trial is testingA SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy VolunteersWho this might be right forOsteoarthritisPainPost Herpetic Neuralgia+3 more iN Therapeutics Co., Ltd. 104
Early research (Phase 1)Study completedNCT01956305What this trial is testingRandomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose StudyWho this might be right forType 2 Diabetes Mellitus Daiichi Sankyo 48
Early research (Phase 1)Study completedNCT02583594What this trial is testingCharacterize Subcutaneous or Intravenous Alemtuzumab in Patients With Progressive Multiple SclerosisWho this might be right forProgressive Multiple Sclerosis Genzyme, a Sanofi Company 24
Early research (Phase 1)Study completedNCT01818869What this trial is testingTo Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy SubjectsWho this might be right forSafety,Tolerability,Healthy Subjects AstraZeneca 8
Early research (Phase 1)Looking for participantsNCT06946641What this trial is testingA Phase I Study of QLS12010 Capsules: Safety, Tolerability, PK, PD, and Food Effects in Healthy Adults and Moderate to Severe Atopic Dermatitis PatientsWho this might be right forAtopic DermatitisHidradenitis Suppurativa (HS)Rheumatoid Arthritis (RA) Shanghai Qilu Pharmaceutical Research and Development Center LTD 102
Early research (Phase 1)Study completedNCT05466422What this trial is testingMK-2214 in Adults With Mild Cognitive Impairment or Mild-to-Moderate Alzheimer's Disease (MK-2214-002)Who this might be right forAlzheimer Disease Merck Sharp & Dohme LLC 34
Early research (Phase 1)Study completedNCT03647228What this trial is testingA Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Multiple Doses of IONIS-ENaCRx in Healthy Volunteers and Patients With Cystic FibrosisWho this might be right forHealthy SubjectsCystic Fibrosis Ionis Pharmaceuticals, Inc. 98
Early research (Phase 1)Study completedNCT03235219What this trial is testingA Phase 1b Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of JNJ-64565111 in Participants With Type 2 Diabetes MellitusWho this might be right forDiabetes Mellitus, Type 2 Janssen Research & Development, LLC 39
Early research (Phase 1)Ended earlyNCT00943371What this trial is testingA Single-Dose Study of MK6349 in Patients With Type 2 Diabetes (6349-002)Who this might be right forType 2 Diabetes Mellitus Merck Sharp & Dohme LLC 28
Early research (Phase 1)Study completedNCT01273571What this trial is testingA Pharmacokinetic and Pharmacodynamic Study of Metformin and Canagliflozin in Healthy Adult VolunteersWho this might be right forHealthy Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 18
Early research (Phase 1)Looking for participantsNCT07767175What this trial is testingA First-in-human Research Study on How NNC0721-8060 Works in People Living With Overweight or ObesityWho this might be right forOverweightObesity Novo Nordisk A/S 142
Early research (Phase 1)Study completedNCT01060475What this trial is testingSafety and Tolerability of LIM-0705 in Healthy Male SubjectsWho this might be right forHealthy Limerick BioPharma 44
Testing effectiveness (Phase 2)Study completedNCT06309277What this trial is testingA Clinical Study to Evaluate of Single and Multiple Oral Doses of GM-1020 in Patients With MDDWho this might be right forMajor Depressive Disorder Gilgamesh Pharmaceuticals 46
Early research (Phase 1)Study completedNCT01290575What this trial is testingMultiple Ascending Dose Study of BMS-820132 in Patients With Type 2 DiabetesWho this might be right forType 2 Diabetes Bristol-Myers Squibb 67
Early research (Phase 1)Study completedNCT01898364What this trial is testingSafety and Efficacy Evaluation of Repeat neoGAA Dosing in Late Onset Pompe Disease Patients.Who this might be right forPompe DiseaseGlycogen Storage Disease Type II (GSD II)Acid Maltase Deficiency Genzyme, a Sanofi Company 24
Early research (Phase 1)Study completedNCT04302064What this trial is testingAssess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single-Ascending and Multiple Doses of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Healthy Japanese ParticipantsWho this might be right forHealthy Participants Ionis Pharmaceuticals, Inc. 24
Testing effectiveness (Phase 2)Study completedNCT05762471What this trial is testingPhase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes MellitusWho this might be right forOverweight or ObesityType2 Diabetes Mellitus Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 142
Early research (Phase 1)Study completedNCT00971802What this trial is testingEvaluate The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of PF-03882845 In Healthy VolunteersWho this might be right forHealthy Volunteers Pfizer 50